Use and diversion of medical marijuana among adults admitted to inpatient psychiatry

American Journal of Drug and Alcohol Abuse

Volumn 41, Issue 2, 2015, Pages 166-172

  Nussbaum, Abraham M ^a,b   Thurstone, Christian ^a,b   McGarry, Laurel ^b   Walker, Brendan ^c   Sabel, Allison L ^c,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Cannabis; Diversion; Inpatient psychiatry; Medical marijuana; Substance use; Survey

Indexed keywords

MEDICAL CANNABIS;

ADULT; ARTICLE; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRESCRIPTION DRUG DIVERSION; PREVALENCE; SUBSTANCE ABUSE; UNITED STATES; ADOLESCENT; AGED; CANNABIS SMOKING; HOSPITAL PATIENT; MARIJUANA ABUSE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INPATIENTS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MIDDLE AGED; PRESCRIPTION DRUG DIVERSION; PREVALENCE; YOUNG ADULT;

EID: 84923337121     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2014.949727     Document Type: Article

References (27)

1. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33:195-209.
2. Nussbaum AM, Thurstone C, Binswanger IA. Medical marijuana use and suicide attempt in a patient with major depressive disorder. Am J Psychiatry 2011;168:779-781.
3. Nussbaum AM, Boyer JA, Kondrad EC. "But my doctor recommended pot": medical marijuana and the patient-physician relationship. J Gen Intern Med 2011;26:1364-1367.
4. Colorado Constitution. 0-4-287-Article XVIII-Miscellaneous Art. XVIII-Miscellaneous. Enacted 7 November 2000. Available at: http://www.colorado.gov/cs/Satellite/CDPHE-CHEIS/CBON/1251593017076 [last accessed 21 Feb 2014].
5. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002;159:379-387.
6. Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005;59: 291-295.
7. Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy 2013;24: 511-516.
8. United Nations Office on Drugs and Crime (UNODC). World Drug Report. United Nations publication, Sales No. E.12.XI.1, 2012.
9. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings. Rockville, MD; 2010.
10. Hall W, Pacula RK. Cannabis use and dependence: public health and public policy. Cambridge, UK: Cambridge University Press; 2003.
11. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set-Admissions (TEDS-A), 2008 [Computer file]. ICPSR27241-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2010-03-31; 2008.
12. van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 2007;102:1251-1260.
13. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003;98: 1493-1504.
14. Pedersen W. Does cannabis use lead to depression and suicidal behaviors? A populations-based longitudinal study. Acta Psychiatr Scand 2008;118:395-403.
15. Meier MH, Caspi A, Ambler A, Harrington HJ, Houts R, Keefe RSE, McDonald K, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012;109:E2657-E2664.
16. Large M, Sharma S, Comptom MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011;68:555-561.
17. Lev-Ran S, Segev A, Braw Y, Levkovitz Y. Neurocognitive functions of heavy cannabis using schizophrenia patients. Eur Psychiatry 2012;27:365-368.
18. Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol Psychiatry 2014;19:536-543.
19. Bahorik AL, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 2013;108: 1259-1269.
20. Swartz R. Medical marijuana users in substance abuse treatment. Harm Reduct J 2010;7(1):3.
21. Thurstone C, Lieberman SA, Schmiege SJ. Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend 2011;118:489-492.
22. Salomonsen-Sautel S, Sakai JT, Thurstone C, Corley R, Hopfer C. Medical marijuana use among adolescents in substance abuse treatment. J Am Acad Child Adolesc Psychiatry 2012;51:694-702.
23. Arizona Criminal Justice Commission. Arizona Youth Survey State Report 2012. Available at: http://www.azrapeprevention.org/sites/azrapeprevention.org/files/AYS%202012%20Report%20Final% 2012%2031%202012-0.pdf [last accessed 21 Feb 2014].
24. Kondrad EC, Reid A. Colorado family physician's attitudes toward medical marijuana. J Am Board Fam Med 2013;26:52-60.
25. Ingold J. Hickenlooper: 1 billion in pot sales expected next fiscal year. Denver Post, 19 February 2014. Available at: http://www.thecannabist.co/2014/02/19/john-hickenlooper-coloradogoversnor-marijuana-tax-money-exceeds-expectations/5087/[last accessed 21 Feb 2014].
26. Gonzalez R, Swanson JM. Long-term effects of adolescent-onset and persistent use of cannabis. Proc Natl Acad Sci USA 2012;109: 15970-15971.
27. Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull 2008;34:555-567.